Works matching IS 00070920 AND DT 2025 AND VI 132 AND IP 3

Results: 8

The accuracy of fluorine 18-labelled prostate-specific membrane antigen PET/CT and MRI for diagnosis of prostate cancer in PSA grey zone: Clinical Studies.

Published in:

British Journal of Cancer, 2025, v. 132, n. 3, p. 253, doi. 10.1038/s41416-024-02934-x

By:

Luo, Liang;
Wang, Ruiyan;
Bai, Lu;
Shang, Jin;
Wang, Xinyi;
Chang, Ruxi;
Dong, Weixuan;
Li, Yang;
Li, Yan;
Liang, Hua;
Xie, Hongjun;
Duan, Xiaoyi

Publication type:

Article

Women's perspectives of molecular breast imaging: a qualitative study: Epidemiology.

Published in:

British Journal of Cancer, 2025, v. 132, n. 3, p. 276, doi. 10.1038/s41416-024-02930-1

By:

Elliott, Helen;
Allen, A. Joy;
Forester, Nerys D.;
Graziadio, Sara;
Jones, W. S.;
Lendrem, Beverley Clare;
Pearce, Mark S.;
Powell, Timothy;
Scott, Jason;
Bray, Alison

Publication type:

Article

Dietary intake of isoflavones and coumestrol and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial: Epidemiology.

Published in:

British Journal of Cancer, 2025, v. 132, n. 3, p. 266, doi. 10.1038/s41416-024-02929-8

By:

Liu, Chunliang;
Reger, Michael;
Fan, Hao;
Wang, Jintao;
Zhang, Jianjun

Publication type:

Article

Post-diagnosis statin use and survival among head and neck cancer patients: a cohort study in a universal health care system: Epidemiology.

Published in:

British Journal of Cancer, 2025, v. 132, n. 3, p. 259, doi. 10.1038/s41416-024-02925-y

By:

Lin, Jie;
Orestes, Michael I.;
Shriver, Craig D.;
Zhu, Kangmin

Publication type:

Article

Identification of diagnostic biomarkers in prostate cancer-related fatigue by construction of predictive models and experimental validation: Molecular Diagnostics.

Published in:

British Journal of Cancer, 2025, v. 132, n. 3, p. 283, doi. 10.1038/s41416-024-02922-1

By:

Chen, Ming;
Zhou, Siqi;
He, Xiongwei;
Wen, Haiyan

Publication type:

Article

Heterogeneity of tertiary lymphoid structures predicts the response to neoadjuvant therapy and immune microenvironment characteristics in triple-negative breast cancer: Translational Therapeutics.

Published in:

British Journal of Cancer, 2025, v. 132, n. 3, p. 295, doi. 10.1038/s41416-024-02917-y

By:

Wang, Qing;
Yu, Yushuai;
Wang, Chenxi;
Jiang, Zirong;
Li, Jialu;
Li, Xiaofen;
Huang, Xiewei;
Song, Ying;
Li, Zhenhui;
Tang, Shicong;
Song, Chuangui

Publication type:

Article

Long term efficacy of first-line afatinib and the clinical utility of ctDNA monitoring in patients with suspected or confirmed EGFR mutant non-small cell lung cancer who were unsuitable for chemotherapy: Clinical Studies.

Published in:

British Journal of Cancer, 2025, v. 132, n. 3, p. 245, doi. 10.1038/s41416-024-02901-6

By:

Popat, Sanjay;
Januszewski, Adam;
O'Brien, Mary;
Ahmad, Tanya;
Lewanski, Conrad;
Dernedde, Ulrike;
Jankowska, Petra;
Mulatero, Clive;
Shah, Riyaz;
Hicks, Jonathan;
Geldart, Tom;
Cominos, Mathilda;
Gray, Gill;
Spicer, James;
Bell, Karen;
Roitt, Simon;
Morris, Clive;
Ngai, Yenting;
Hughes, Laura;
Hackshaw, Allan

Publication type:

Article

Immune therapeutic strategies for the senescent tumor microenvironment: Cellular and Molecular Biology.

Published in:

British Journal of Cancer, 2025, v. 132, n. 3, p. 237, doi. 10.1038/s41416-024-02865-7

By:

Yasuda, Tadahito;
Alan Wang, Y.

Publication type:

Article